Cellectis S.A. (NASDAQ:CLLS) Q3 2024 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Posts Tagged ‘NASDAQ:CLLS’
Cellectis S.A. (NASDAQ:CLLS) Q3 2024 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Cellectis S.A. (NASDAQ:CLLS) Q1 2024 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Cellectis First Quarter 2024 Earnings Call.
Cellectis S.A. (NASDAQ:CLLS) Q3 2023 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2023 Earnings Calls. [Operator Instructions].
Cellectis S.A. (NASDAQ:CLLS) Q2 2023 Earnings Call Transcript
Operator: Good morning, and everyone, welcome to Cellectis Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Cellectis S.A. (NASDAQ:CLLS) Q1 2023 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to Cellectis First quarter 2023 Earnings Call. [Operator Instructions].
Cellectis S.A. (NASDAQ:CLLS) Q4 2022 Earnings Call Transcript
Operator: Good morning, everyone and welcome to Cellectis Fourth Quarter and Full Year 2022 Earnings Conference Call.
10 Genomics Stocks in Cathie Wood’s Portfolio That Are Underperforming
In this article, we discuss 10 genomics stocks in Cathie Wood’s portfolio that are underperforming.
15 Worst Stock Picks of Cathie Wood
In this article, we discuss the 15 worst stock picks of Cathie Wood.
10 Best Biotech Stocks Under $20 in Cathie Wood’s Portfolio
In this article, we discuss the 10 best biotech stocks under $20 in Cathie Wood's portfolio.
10 Best Cheap Tech Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best tech stocks to buy according to Cathie Wood.
Is CLLS A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Cellectis SA (CLLS): Hedge Funds Are Snapping Up
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Did Hedge Funds Drop The Ball On Cellectis SA (CLLS) ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Is Cellectis SA (CLLS) Going To Burn These Hedge Funds ?
The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive...
Is Cellectis SA (CLLS) A Good Stock To Buy?
How do we determine whether Cellectis SA (NASDAQ:CLLS) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the ...
Should You Avoid Cellectis SA (CLLS)?
Is Cellectis SA (NASDAQ:CLLS) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research.
Market Movers Today: Switch Inc (SWCH), Longfin Corp (LFIN), Cellectis SA (ADR) (CLLS), Adamas Pharmaceuticals Inc (ADMS), and More
What happened: Shares of Switch (NYSE:SWCH) have gotten crushed today, down by 16% as of 12:20 p.m. EDT, after the data center specialist reported fourth-quarter earnings.
Cellectis SA (ADR) (CLLS) Just Made A Big Step Forward In CAR-T
Cellectis SA (ADR) (NASDAQ:CLLS) just announced that the FDA has granted it approval to proceed with the clinical development of a drug called UCART123.
Do Hedge Funds Love Cellectis SA (ADR) (CLLS)?
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
